Feb 20, 2020
Scott Gottlieb, former FDA Commissioner, to Deliver Keynote at MHA 2020 Business Summit
Sep 17, 2019
Former FDA Commissioner Scott Gottlieb Joins Aetion's Board of Directors
Sep 16, 2019
Former US Health & Human Services Administrator Named Keynoter
Jun 03, 2019
Scott Gottlieb to Keynote GNS Healthcare's Precision Medicine Forum
Jun 03, 2019
REGENXBIO Selects Skyland PIMS(TM) as their Process and Product Data Management Software System
Mar 28, 2019
Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Subcommittee on Appropriations on FDA's Fiscal Year 2020 budget
Mar 27, 2019
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen agency's safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products
Mar 05, 2019
Wake Up FDA Campaign Statement on FDA Commissioner Scott Gottlieb's Resignation
Feb 26, 2019
Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA's modern approach to advanced pharmaceutical manufacturing
Feb 21, 2019
Statement from FDA Commissioner Scott Gottlieb, M.D., on additional steps by the agency to support the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes
Feb 07, 2019
FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines
Jan 28, 2019
Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on a record year for device innovation
Jan 16, 2019
FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy
Jan 09, 2019
The Future of FDA's Electronic Safety Surveillance
Dec 13, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDA's Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development
Dec 11, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency's biosimilars policy framework
Dec 06, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA's new strategic framework to advance use of real-world evidence to support development of drugs and biologics
Nov 29, 2018
FDA warns company for selling e-liquids that resemble kid-friendly foods as part of the agency's ongoing Youth Tobacco Prevention Plan
Nov 27, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on how modern predicates can promote innovation and advance safety and effectiveness of medical devices that use 510(k) pathway
Nov 27, 2018
Statement by FDA Commissioner Scott Gottlieb, M.D., on risk of heavy metals, including nickel and lead, found in some kratom products